ZenaTech Letter to Shareholders Outlines 316% Q2 Revenue Growth and Seventh Consecutive Quarter of Sequential Growth October 1, 2026
PharmaTher Enters into Exclusive North American Distribution Agreement with Craft Health for CraftMake(TM) Pharmaceutical 3D Printing Platform October 1, 2026
Radnostix Signs Definitive Agreement to Divest DUF6 and Fluorine Assets to NANO Nuclear October 1, 2026